Trial Profile
A Randomized, Single Blinded, Controlled, Multi Center Phase 4 Study for Induction of Remission in Active Pediatric Crohn's Disease, Using 2 Months Antibiotic Course of Azithromycin Combined With Metronidazole vs. Metronidazole Alone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary) ; Metronidazole (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms AZCRO
- 02 Feb 2018 Primary endpoint (Response rate at 8 weeks) has not been met, as per results published in the Gut.
- 02 Feb 2018 Results comparing response rate of Azithromycin and metronidazole versus metronidazole-based therapy, published in the Gut.
- 07 Dec 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.